Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-01-19

FDA Approved: ATOMOXETINE HYDROCHLORIDE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved a supplemental application for atomoxetine hydrochloride from Apotex Corp., approving a generic version of the ADHD medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atomoxetine hydrochloride (Atomoxetine hydrochloride)

Snippet

SUPPL AP for ATOMOXETINE HYDROCHLORIDE (ATOMOXETINE HYDROCHLORIDE)